Risk Assessments
Risk assessment is the regulation of quantitative or qualitative assessment of risk associated to a well-defined situation and hazard. An acceptable risk is a risk that is tolerated generally because the cost or difficulty of applying an effective counter measure for the related vulnerability goes beyond the expectation of loss. Health risk assessment consists of variations, such as risk as the type and severity of response, with or without a probabilistic context. The agriculture, aerospace, nuclear, rail, military and oil industries have a long history of dealing with risk assessment.
- Principles and theory of risk assessment and management
- Dynamic risk assessment and characterization
- Integration of risk models and quantifications
- Risk assessment policy, standards and regulations
- Integrated risk assessment and safety management
- Risk-based decision making and risk management
- Advanced concepts and information technologies in risk assessment
- Risk analysis hazard identification
- Exposure assessment
- Comparative risk assessment
- Risk analysis
- Dose response assessment
- Risk management
- Advances in cancer risk assessment
- Risk assessment in health complications
- Risk perception and communications
Related Conference of Risk Assessments
November 27-28, 2025
7th International Conference on Clinical Pharmacology and Toxicology
Zurich, Switzerland
Risk Assessments Conference Speakers
Recommended Sessions
- Pharmacology
- Reproductive and Developmental Toxicology
- Biomarkers
- Clinical and Applied Toxicology
- Computational Toxicology
- Drug Toxicology
- Environmental Toxicology
- Experimental and Toxicologic Pathology
- Food and Chemical Toxicology
- Forensic Toxicology
- Human Health Toxicology
- Molecular and Cellular Toxicology
- Occupational and Industrial Toxicology
- Risk Assessments
- Toxicity Testing Market & Business Opportunities
- Toxicogenomics
- Toxicological Pharmacovigilance
- Toxicology
- Toxicology Global Market
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)